Department of Pathology
  Brigham and Women's Hospital
  A teaching Affliate of Harvard Medical School
Login Skip Navigation Links
  Skip Navigation Links
HomeExpand Home


Submit new announcement
David Hwang, M.D.

Pathologist, Harvard Medical School
Thoracic Pathology Fellow

Academic Activities:

75 Francis Street
AL-3-117, Amory Building
Boston,MA 02115
Education and Training:

College - : University of Chicago BS in Chemistry
Medical School - : University of Chicago Pritzker School of Medicine MD

Clinical Specialties: Research Interests: Publication:
  1. Song J, Li M, Hwang DH, Ricciotti RW, Chang A. The outcome of abstracts presented at the United States and Canadian Academy of Pathology annual meetings. Modern Pathology 23, 682-685, May 2010.
  2. Schwartz MJ, Liu H, Hwang DH, Kawamoto H, and Scherr DS. Antitumor effects of an imidazoquinoline in renal cell carcinoma. Urology 73(5):1156-1162, May 2009.
  3. Schwartz MJ, Hwang DH, Hung AJ, Han J, McClain JW, Shemtov MM, Te AE, Sosa RE, Vaughan ED Jr, Scherr DS. Negative influence of changing biopsy practice patterns on the predictive value of prostate-specific antigen for cancer detection on prostate biopsy. Cancer 112(8):1718-25, Mar 2008.
  4. Liu H, Schwartz MJ, Hwang DH, Scherr DS: Tumour growth inhibition by an imidazoquinoline is associated with c-Myc down-regulation in urothelial cell carcinoma. British Journal of Urology International 101 (7): 894-901, Jan 2008.
  5. Smith EB, Schwartz M, Kawamoto H, You X, Hwang D, Liu H, Scherr DS: Antitumor effects of imidazoquinolines in urothelial cell carcinoma of the bladder. Journal of Urology 177 (6): 2347-51, June 2007.
<June 2019>

<Monday, June 24, 2019>
8:00 AM

Cotran Conference Center
8:00 AM

Autopsy suite
9:00 AM

Clinical Lab conference room
3:00 PM

Dammin signout suite
Copyright 2008 - 2019, BWH Pathology, All rights reserved.